GC63887
SGC-SMARCA-BRDVIII
Also known as tert-butyl 4-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate
SGC-SMARCA-BRDVIII is a potent and selective inhibitor of SMARCA2/4 and PB1(5), with Kds of 35 nM, 36 nM, and 13 nM, respectively
ChemicalCAS1997319-84-2MW371.43FormulaC19H25N5O3
- CAS number
- 1997319-84-2
- Molecular weight
- 371.43
- Formula
- C19H25N5O3
- Solubility
- DMSO ： 25 mg/mL (67·31 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- AQTNUGRRZDRZIA-UHFFFAOYSA-N
- Catalogue number
- GC63887
- Brand
- GLPBIO
Computed properties PubChem CID 137045929 · XLogP 1.6 · TPSA 105 Ų · H-bond donors 2
- XLogP
- 1.6
- TPSA
- 105 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES CC(C)(C)OC(=O)N1CCN(CC1)C2=CC(=NN=C2N)C3=CC=CC=C3O
Computed descriptors from PubChem (CID 137045929), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il